Atlas Trials

An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy

Clinical trial NCT01141751 · COMPLETED

Trial details

NCT number
NCT01141751
Sponsor
Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2005-09-01
Primary completion
2011-06-01
Enrollment
334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.